Market Cap
$2.0B
INSP
Inspire Medical Systems, Inc.
$69.97 ▼ -1.14%
Prev close $70.78Market cap$2.0B
ConsensusSell
12-mo target$63.80 (-8.8%)
▲ Neutral
Analyst conviction 4/10
Insider Selling Cluster (2 insiders)33 New Institutional Positions17 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on INSP right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Hold (38%)
Inst. Holders
50 funds
Inst. Value
$1.3B
Inst. Activity
33 buys / 17 sells
Insider Activity
$0.00 buy / $233.3K sell
Insider Net $
-$233.3K
SEC Reports
8
Price chart 30d +12.6%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 other
Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire),
Aug 31, 2026 Insider
Kelly Jason P was granted 6,350 shares
See Remarks
Aug 7, 2026 Insider
Kelly Jason P sold 963 shares
See Remarks @ $59.55 ($57.3K)
Jul 31, 2026 Insider
Jul 27, 2026 SEC Mann Melissa surrendered for taxes 326 shares
Chief People Officer @ $50.21 ($16.4K)
Michael H. Carrel filed an initial Statement of Beneficial Ownership (Form 3) with the SEC, reporting no securities owne
3 — Impact 1/10
Inspire Medical Systems appointed Michael H. Carrel, CEO of AtriCure (ATRC), to its Board of Directors effective July 20
8-K — Impact 2/10
Inspire Medical Systems announced the retirement of board member Casey M. Tansey, effective July 30, 2026, after more th
8-K — Impact 2/10
Jun 30, 2026 Inst.
BlackRock, Inc. — ADD
4,737,519 shares ($211.3M)
Analyst ratings buy % -47.2%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
38% rate it Buy or better · 24 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Oct 2, 2026 | Freedom Capital Markets | MAINTAIN | Buy | 46% |
| Oct 1, 2026 | RBC Capital | MAINTAIN | Sector Perform | 55% |
| Sep 21, 2026 | Freedom Capital Markets | MAINTAIN | Buy | 46% |
| Sep 11, 2026 | Stifel | MAINTAIN | Buy | 54% |
| Aug 4, 2026 | JP Morgan | MAINTAIN | Neutral | 55% |
| Aug 4, 2026 | Mizuho | MAINTAIN | Outperform | 52% |
| Aug 4, 2026 | Oppenheimer | UPGRADE | Outperform | 52% |
| Aug 4, 2026 | Truist Securities | REITERATE | Hold | 55% |
| Aug 4, 2026 | Evercore ISI Group | MAINTAIN | In-Line | 59% |
| Aug 4, 2026 | Piper Sandler | MAINTAIN | Neutral | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 4 | 5 | 13 | 2 | 0 | 38% | |
| Aug 1, 2026 | 3 | 6 | 13 | 2 | 0 | 38% | |
| Jul 1, 2026 | 3 | 6 | 15 | 1 | 0 | 36% | |
| Jun 1, 2026 | 3 | 5 | 15 | 1 | 0 | 33% | |
| May 1, 2026 | 4 | 7 | 14 | 0 | 0 | 44% | |
| Apr 1, 2026 | 4 | 7 | 14 | 0 | 0 | 44% | |
| Mar 1, 2026 | 5 | 7 | 13 | 0 | 0 | 48% | |
| Feb 1, 2026 | 6 | 9 | 10 | 0 | 0 | 60% |
Price targets
Where 15 covering analysts think INSP trades over the next 12 months.
$63.80 -8.8% upside Sell
Current$69.97 Low$40.00 Median$60.00 High$97.00 15 analysts
$40.00$97.00
Analyst rating Hold· 2.7/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
8 SEC filing reports analyzed · 0 bullish, 1 bearish, 0 mixed, 7 neutral · avg impact 2.9/10.
NEUTRAL31/10
Michael H. Carrel filed an initial Statement of Beneficial Ownership (Form 3) with the SEC, reportin
Jul 27, 2026
NEUTRAL8-K2/10
Inspire Medical Systems appointed Michael H. Carrel, CEO of AtriCure (ATRC), to its Board of Directo
Jul 24, 2026
NEUTRAL8-K2/10
Inspire Medical Systems announced the retirement of board member Casey M. Tansey, effective July 30,
Jul 22, 2026
BEARISHPRESS-RELEASE6/10
Inspire Medical Systems (INSP) reported Q1 2026 EPS of -$0.39, a 59.1% miss vs consensus of -$0.25,
Jul 6, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
other
Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the devel
Sep 18, 2026
short_volume
Short Volume: INSP — 81.9% short (0.5M / 0.6M)
Short: 528,198 | Exempt: 147 | TRF Vol: 645,199 | Short Ratio: 81.9% | Off-exchange volume (dark pool + OTC)
Sep 14, 2026
short_volume
Short Volume: INSP — 59.9% short (0.3M / 0.5M)
Short: 321,428 | Exempt: 0 | TRF Vol: 536,890 | Short Ratio: 59.9% | Off-exchange volume (dark pool + OTC)
Sep 11, 2026
short_volume
Short Volume: INSP — 56.0% short (0.4M / 0.6M)
Short: 352,691 | Exempt: 0 | TRF Vol: 629,431 | Short Ratio: 56.0% | Off-exchange volume (dark pool + OTC)
Aug 24, 2026
ftd
FTD: INSP — 13,400 shares ($0.8M) failed to deliver
Settlement: 20260824, Price: $62.36, FTD Value: $835,624, INSPIRE MED SYS INC COM
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.09 | $-0.13–$0.17 | -77.1% | +0.0% | 2↑ 8↓ | $0.2B | 13 |
| Next Q | $0.91 | $0.79–$1.06 | -44.7% | +0.0% | 6↑ 4↓ | $0.2B | 13 |
| Current FY | $1.25 | $1.17–$1.34 | -48.5% | +0.1% | 12↑ 0↓ | $0.9B | 14 |
| Next FY | $1.54 | $1.33–$1.78 | 23.3% | +0.1% | 11↑ 1↓ | $0.9B | 14 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.087 | — |
| 7d ago | $0.087 | — |
| 30d ago | $0.087 | — |
| 60d ago | $0.141 | -0.054 |
| 90d ago | $0.151 | -0.064 |
Institutional ownership
Which big funds own INSP (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $1.3B total value (28,808,690 shares) as of 2026-Q2. Top holders: BlackRock,, WELLINGTON, VANGUARD. Net buying activity: 33 institutions added/increased vs 17 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 4,737,519 | $211.3M | 16.5% | ADD +33.5% |
| WELLINGTON MANAGEMENT GROUP LLP | 2,382,660 | $106.3M | 8.3% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2,088,961 | $93.2M | 7.3% | ADD +27.6% |
| AQR CAPITAL MANAGEMENT LLC | 1,856,800 | $80.9M | 6.3% | — |
| UBS Group AG | 1,645,511 | $73.4M | 5.7% | DOUBLED +157.5% |
| D. E. Shaw & Co., Inc. | 1,470,462 | $65.6M | 5.1% | — |
| NOMURA HOLDINGS INC | 1,369,410 | $61.1M | 4.8% | NEW |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,270,928 | $56.7M | 4.4% | — |
| STATE STREET CORP | 1,206,494 | $53.8M | 4.2% | ADD +26.2% |
| Assenagon Asset Management S.A. | 864,395 | $38.6M | 3.0% | ADD +66.2% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | ADD | 3,549,554 | 4,737,519 | +33.5% | $211.3M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | ADD | 1,637,173 | 2,088,961 | +27.6% | $93.2M |
| UBS Group AG | DOUBLED | 638,928 | 1,645,511 | +157.5% | $73.4M |
| NOMURA HOLDINGS INC | NEW | — | 1,369,410 | — | $61.1M |
| STATE STREET CORP | ADD | 956,011 | 1,206,494 | +26.2% | $53.8M |
| Assenagon Asset Management S.A. | ADD | 520,174 | 864,395 | +66.2% | $38.6M |
| MORGAN STANLEY | TRIM | 1,450,634 | 791,222 | -45.5% | $35.3M |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | 510,234 | 700,836 | +37.4% | $31.3M |
| CITADEL ADVISORS LLC | ADD | 394,076 | 506,334 | +28.5% | $22.6M |
| BNP PARIBAS FINANCIAL MARKETS | ADD | 319,758 | 428,069 | +33.9% | $19.1M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
16 insiders, 46 transactions. Net -$233.3K — $0.00 bought, $233.3K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Kelly Jason P | See Remarks | AWARD | 6,350 | — | — |
| Aug 7, 2026 | Kelly Jason P | See Remarks | SELL | 963 | $59.55 | $57.3K |
| Jul 31, 2026 | Mann Melissa | Chief People Officer | TAX W/H | 326 | $50.21 | $16.4K |
| Jul 20, 2026 | CARREL MICHAEL H | Director | AWARD | 5,631 | — | — |
| Jul 15, 2026 | Melenikiotou Georgia | Director | AWARD | 344 | — | — |
| Jul 15, 2026 | Tansey Casey M | Director | AWARD | 346 | — | — |
| Jul 15, 2026 | Ellis Gary Lee | Director | AWARD | 581 | — | — |
| Jul 15, 2026 | Broader Shelley G | Director | AWARD | 383 | — | — |
| May 15, 2026 | Rondoni John | See Remarks | SELL | 2,641 | $43.28 | $114.3K |
| May 14, 2026 | Rondoni John | See Remarks | SELL | 700 | $43.01 | $30.1K |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for INSP.
Shares short
3,928,250
Settlement Sep 15, 2026
Change vs prior
+7.4%
Semi-monthly cycle
Days to cover
4.9
At avg daily volume
Of shares outstanding
≈13.6%
Estimate — not % of float
All INSP filing & press-release reports (8)
- 3 reportJul 27, 2026
- 8-K reportJul 24, 2026
- 8-K reportJul 22, 2026
- PRESS-RELEASE reportJul 6, 2026
- INST-CLUSTER reportJun 11, 2026
- 144 reportMay 8, 2026
- PRESS-RELEASE reportApr 6, 2026
- DEFA14A reportMar 20, 2026